Introduction
============

The epidemiological data has supported the premise that HIV transmission via saliva is low or non-existent due to inhibitory factors in saliva. The risk of HIV-1 infection following human bite although epidemiologically insignificant, but it is biologically possible \[[@B1],[@B2]\]. Animal studies with rhesus macaques shows the infants are more susceptible to oral infections \[[@B3]\]. The oral trauma, co-infections with other sexually transmitted pathogens, periodontal diseases, concomitant ulcerative lesions, further enhance oral HIV transmission. The human bites as a rare risk factor for HIV transmission \[[@B4]\]. Some patients are hyper-excretors \[[@B5]\] they have high levels of infectious HIV in their saliva than in blood. These hyper-excretors may be at risk of transmitting the virus to their partners even though the blood viral load is low.

An interesting case of HIV transmission following a human bite is reported.

Case report
===========

On 29 March 2010, a 44 year\'s old man (Mr.A) a known case of NIDDM (Non-insulin dependent diabetes mellitus) and hypertension for past four years under treatment was brought to the hospital with history of high grade fever and increasing drowsiness for past four days.

Clinical examination revealed a drowsy febrile patient without focal neurological deficit or meningeal signs. A clinical diagnosis of malaria, metabolic encephalopathy with sepsis was made, later the patient had two episodes of generalized tonic-clonic convulsions and was treated with midazolam and Loarazepam followed by phosphenytoin along with IV Artesunate. Basic investigations were normal. Malarial parasites were not detected. Computerized tomography (CT) Brain showed nonspecific changes. CSF was suggestive of viral meningitis. Despite inj. Acyclovir drowsiness continued. He was negative for HBV, HCV, and HSV. The HIV Duo test was weakly positive. (Mr. A) did not provide any history of unprotected sex or multiple sex partners, nor any intravenous drug use in past or present, His spouse is HIV negative, The HIV-I viral load on the 4^th^day of hospitalization was \>750,000 copies/ml (Cobas Taqman 48 Real time PCR) and The CD4^+^cell count was 396 cells/mm^3^. A diagnosis of acute HIV infection was considered and TDF+FTC+EFV were started as per DHHS guidelines.

As the sensorium improved, details from patient revealed that his foster son (Mr.X) who was HIV-1 positive, due to heterosexual acquisition. He was drug naïve with CD4 cell count 460 cells/mm^3.^On 1^st^March father and son duo, had an argument during which the son severely bit the left thumb of the father (Figure [1](#F1){ref-type="fig"}). During the incident the thumb nail of (Mr.A) came out leaving behind a raw bleeding nail bed.

![**shows the condition of the nail four weeks after the bite**.](1742-6405-8-16-1){#F1}

Clinical examination of (Mr.X) revealed that his oral hygiene was good, absence of oral ulcers, caries no bleeding in gums. There were no physical injury, cuts or scratches occurred during the argument. The patient consulted his family physician who did not advice PEP, as salivary transmission of HIV is rare and negligible.

On 29 March 2010, four weeks after the incidence.(Mr A) was hospitalized and his HIV Duo test was weakly positive and his viral load was high (2,470,000 copies/ml). The case thus indicates acquisition of HIV infection through saliva not contaminated with blood, following a human bite. The blood samples of both the father-son duo and saliva of the source (Mr.X) were collected on 12 April 2010, these samples were analyzed for confirmation of HIV DNA by amplifying C2-V3 Region of HIV1C envelope gene and further confirmed by PCR and sequencing. Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-hypaque method. DNA from these PBMCs was extracted using Qiagen DNA mini kit and used for PCR \[Qiagen, GmbH, Hilden, Germany\]. The C2-V3 region of *env*gene was amplified (Figure [2](#F2){ref-type="fig"}) by nested PCR by heteroduplex mobility assay (HMA) using primers \[[@B6]\] obtained from NIH AIDS Research and Reference Reagent Programme (NIH, Bethesda, USA) to determine HIV variants and subtypes.

![**PCR amplification of C2-V3 region of HIV1C *env*gene from PBMCs**.](1742-6405-8-16-2){#F2}

The C2-V3 region of second round product was sequenced. Sequence revealed 91% homology between Mr.A and Mr. X (Table [1](#T1){ref-type="table"}). The C2-V3 region of HIV1C env gene shows the presence of five N-linked glycosylation (NLG) sites in (Mr A) While in case of (Mr.X) showed six potential NLG sites. The presence of single NLG site at V3 region of HIV 1C *env*gene showed in both the individuals suggesting the possible usages of CCR5 tropic virus.

###### 

Translated Amino acid sequences of C2-V3 Region of HIV 1C *env*gene from Peripheral blood mononuclear cells (PBMCs)

  ID   225                231                    241                      251            260
  ---- ------------------ ---------------------- ------------------------ -------------- ----------------
  A    I**L**KCKD         **NTF NG**T            GPCN                     *NVS*TVQCTHG   I**K**PVVSTQLL
  X    I**I**KCND         **ETS N K**T           GPCN                     *NVS*TVQCTHG   I**R**PVVSTQLL
                                                                                         
       261                271                    281                      295            
  A    L*NGS*LAE**EVV**   II-S**K***NLT*DN       **TE**TIIV**Q**L**D**E   **A**VEIT      
  X    L*NGS*LAE**KEI**   II**R**S**E***NLT*DN   **AK**TIIV**H**L*N*E     **S**VEII      
                                                                                         
       296                301                    311                      321            330
  A    CTRPT              *NNT*RKSIRIG           PGQTFYATGD               IIGNIRRAYC     
  X    CTRPN              *NNT*RKSIRIG           PGQTFYATGD               IIGNIRQAYC     

♦*italic*letters Indicate - NLG sites and **bold**letter indicates variation

♦Starts C2 region of HIV1gp120 followed by V3 region Starts at 296 and end at 330 positions

The virological and immunological parameters of Mr X and Mr A were measured (Table [2](#T2){ref-type="table"}). The HIV-1 viral load in the blood and saliva was estimated using the MagNa pure Compact Nucleic Acid Automated System (Roche Diagnostic GmbH, Germany) with Cobas TaqMan 48 Real time PCR (Roche Molecular Systems Branchburg, NJ, USA).

###### 

Virological and Immunological parameters

  ------------------------------------------------------------------------
  Sample ID   Sample           CD4 count Cells/μl   Viral Load Copies/ml
  ----------- ---------------- -------------------- ----------------------
  Mr.A\       Blood plasma     396                  2,470,000
  (Pt.)                                             

                                                    

  Mr.X\       Blood Plasma     383                  17163
  (Source)                                          

                                                    

              Saliva           NA                   2405

                                                    

              Salivary Cells   NA                   165
  ------------------------------------------------------------------------

NA- not applicable

Evidence from the reports of Healthcare workers (HCWs) bitten by HIV infected toddlers highlights universal precautions should be taken \[[@B7]\]. The potential transmission of HIV 1 by human bite retroviruses has also been reported \[[@B8]\] Detection of HIV-1 in saliva has implications for case identification, clinical monitoring and surveillance for drug resistance \[[@B9]\] which also reveals detectable salivary HIV RNA may be a useful analyte for detection of HIV infection for monitoring responses to ARV therapy.

Conclusions
===========

Our observations revealed transmission of HIV infection from the smear of non-contaminated saliva of \[Mr.X\] on the raw and bleeding nail bed of (Mr.A) To conclude, the family physician should have taken PEP decision after proper evaluation of the severe and bleeding bite. Hence it is necessary to treat the HIV infected human bites with post exposure prophylaxis.
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